Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Sobanski

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
The Lancet. Rheumatology|January 17, 2024
The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorderAlain Lescoat, Catherine Cavalin, Rodney Ehrlich, et al.
Autoimmunity Reviews|January 19, 2018
Altered B lymphocyte homeostasis and functions in systemic sclerosisAlexandra Forestier, Thomas Guerrier, Mathieu Jouvray, et al.
Joint Bone Spine|July 13, 2020
Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional studyAmélie Leurs, Sylvain Dubucquoi, François Machuron, et al.
Clinical and Experimental Rheumatology|September 1, 2020
Hand ultrasound for the diagnosis of scleroderma: a scoring strategy including US items and items from the EULAR/ACR classificationMarine de Saint Riquier, Alice Ballerie, François Robin, et al.
Frontiers in Immunology|July 18, 2022
Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics StudyAurélien Chepy, Solange Vivier, Fabrice Bray, et al.
Respiratory Research|October 15, 2022
Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortalitySébastien Puigrenier, Jonathan Giovannelli, Nicolas Lamblin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional StudyAlain Lescoat, Cécile Marie Yelnik, Guillaume Coiffier, et al.
Frontiers in Immunology|August 15, 2022
Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, Thomas Guerrier, Alain Duhamel, et al.
Journal of Critical Care|June 13, 2026
Intensive care admissions for severe immune-related adverse events associated with immune checkpoint inhibitor therapy: a 10-year cohort studySamuel Pichon, Ghadi Zebian, Charlotte Lacombe, et al.
Rheumatology (Oxford, England)|June 3, 2025
Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR studyVincent Sobanski, Jeska de Vries-Bouwstra, Anna-Maria Hoffmann-Vold, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
The Lancet. Rheumatology|January 17, 2024
The nosology of systemic sclerosis: how lessons from the past offer new challenges in reframing an idiopathic rheumatological disorderAlain Lescoat, Catherine Cavalin, Rodney Ehrlich, et al.
Autoimmunity Reviews|January 19, 2018
Altered B lymphocyte homeostasis and functions in systemic sclerosisAlexandra Forestier, Thomas Guerrier, Mathieu Jouvray, et al.
Joint Bone Spine|July 13, 2020
Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional studyAmélie Leurs, Sylvain Dubucquoi, François Machuron, et al.
Clinical and Experimental Rheumatology|September 1, 2020
Hand ultrasound for the diagnosis of scleroderma: a scoring strategy including US items and items from the EULAR/ACR classificationMarine de Saint Riquier, Alice Ballerie, François Robin, et al.
Frontiers in Immunology|July 18, 2022
Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics StudyAurélien Chepy, Solange Vivier, Fabrice Bray, et al.
Respiratory Research|October 15, 2022
Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortalitySébastien Puigrenier, Jonathan Giovannelli, Nicolas Lamblin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional StudyAlain Lescoat, Cécile Marie Yelnik, Guillaume Coiffier, et al.
Frontiers in Immunology|August 15, 2022
Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, Thomas Guerrier, Alain Duhamel, et al.
Journal of Critical Care|June 13, 2026
Intensive care admissions for severe immune-related adverse events associated with immune checkpoint inhibitor therapy: a 10-year cohort studySamuel Pichon, Ghadi Zebian, Charlotte Lacombe, et al.
Rheumatology (Oxford, England)|June 3, 2025
Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR studyVincent Sobanski, Jeska de Vries-Bouwstra, Anna-Maria Hoffmann-Vold, et al.
Pageof 8